Research Antibodies and Reagents Market Worth 13,276.5 Million USD by 2023

Published On: January 24, 2018

The global research antibodies and reagents market will grow at a CAGR of 6.5% from 2018 to 2023 to reach USD 13,276.5 million by 2023, according to latest publication from Meticulous Research™. The global research antibodies and reagents market is driven by various factors such as rising proteomics & genomic research studies, increase in the funding for research activities, and growing industry-academia collaborations. In addition, growing demand for protein therapeutics & personalized medicines, rising investment & focus on the area of stem cell research, need for new biomarker identification, and emerging Asia-Pacific and Latin American markets provides significant opportunities for various stakeholders in this market. However, various issues related to quality and stability of research antibodies such as cross-reactivity and storage conditions and intense pricing pressure on the leading players are the major challenges affecting the growth of research antibodies and reagents market to some extent.

On the basis of product type, reagents commanded the largest share in the global research antibodies and reagents market in 2017, mainly due to the huge demand for various reagents in many routine assays and techniques with increasing focus on understanding molecular basis of diseases and routine use in target based assays during the basic research.

On the basis of technology, western blotting held the largest share in the global research antibodies and reagents market in 2017. This was mainly attributed to increasing focus on biomedical research for initiating developments in diagnosis and therapy, rising funding for biomarker discovery, and raising demand for antibody & cell-based research and subsequent adoption of this technology in these research studies due to their high sensitivity & specificity to quantify the very low levels of proteins in the sample.

On the basis of application, proteomics held the largest share in the global research antibodies and reagents market in 2017. This was mainly attributed to rising uptake of research antibodies in the significantly growing proteomics market. The upsurge in proteomics research is attributed to the rising need for designing more effective drugs through protein based disease profiling, growing demand for personalized & protein therapeutics, and increasing public & private sector spending on proteomics research.

Based on end user, pharmaceutical and biotechnology industry commanded the largest share in 2017, due to the rising adoption of research antibodies & reagents in the proteomics research and drug discovery and development with the growing focus of industry vendors on innovating therapeutics for various chronic diseases.

Regional market growth trends

Geographically, this market is segmented into North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and RoE), Asia Pacific (Japan, China, India, and RoAPAC), Latin America, and Middle East & Africa. North America commanded the largest share in the global research antibodies and reagents market in 2017, followed by Europe and Asia-Pacific. However, Asia Pacific and Latin America regions are expected to witness significant growth during the forecast period, due to rapidly developing countries, rising preference for these regions due to cost effective research outsourcing, growing investment from government & non-government bodies in this sector, and various technological & infrastructure advancements.

Meticulous Research™ is founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicated market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Meticulous Research™ produces global reports and custom studies for North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa regions. These reports are used by our clients for marketing and strategic planning in various sectors.

Select License Type

Single User -

Multiple User -

Corporate User -

License Details

Single User:

With the help of Single User License, only an individual can use our report either electronically or online. The right to use of the report should be confined only to one authorized computer. Upon buying single user license, buyer must provide the names and email ids of the authorized users of this report.

Multi Users:

Multi-User license permits to access the report from five authorized computers. It does not permit you to share the report with other divisions and subsidiaries of the same company. Upon buying multi-user license, buyer must provide the names and email ids of the authorized users of this report.

Corporate User

With corporate use license, the complete or part of the content of the report can be shared or made available to other persons, other divisions and subsidiaries of same company. However, reproduction or redistribution of the report is prohibited without the prior permission of Meticulous Research.

Dating back from 1970’s, it is believed that use of barcode technology in various healthcare settings has reduced the medication errors and the cost incurred in rehabilitating the patient after the wrong treatment. The adoption of such advanced technologies in the healthcare sector will drastically enhance the operations of hospitals or other healthcare systems.

According to the Journal of Patient Safety, around 400,000 deaths occur each year in the U.S. only. It also reveals that each year preventable adverse events (PAEs) lead to the death of 210,000-400,000 patients who seek care at a hospital.

Corn is the leading source of starch extraction. The corn plant has large capacity for efficiently converting large amounts of radiant energy from the sun into stable chemical energy. This energy is stored as cellulose, oil, and starch in the corn plant and in the corn kernel. The corn plant is also one of nature's greatest multipliers.

Pharmaceutical industry has grown in leaps and bounds during the last three to four decades. Initial emphasis on validation of tablets started across the industry globally sometime in late sixties or early seventies.